𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy

✍ Scribed by Emanuela Balestrieri; Sandro Grelli; Claudia Matteucci; Antonella Minutolo; Gabriella d'Ettorre; Fiorella Di Sora; Francesco Montella; Vincenzo Vullo; Stefano Vella; Cartesio Favalli; Beatrice Macchi; Antonio Mastino


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
141 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The simultaneous expression of 19 apoptosis‐related genes was analyzed by RNA‐protection assay in peripheral blood mononuclear cells of HIV‐infected patients before and during successful antiretroviral therapy (ART). After 12 months of therapy, the expression of the pro‐apoptotic genes FAS, FAS‐L, FAF‐1, FADD, CASPASE‐8, DR3, TRAIL, TNFR‐1, TRADD, and BAX was significantly downregulated with respect to time 0, while that of BCL‐2, BCL‐XL, and MCL‐1 was significantly upregulated. The data suggest that inhibition of cell death in HIV‐positive patients under successful therapy is the result of a complex network of multifactor signaling, correlated with both death and survival of lymphocytes. J. Med. Virol. 79:111–117, 2007. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Predictors of sustained response to ther
✍ Nicola Gianotti; Alessandro Soria; Laura Galli; Antonella Castagna; Massimo Cern 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract In order to evaluate whether a sustained virologic response to therapy resumption after treatment interruption can be achieved in the setting of virologic failure, we reviewed retrospectively the data relating to 56 human immunodeficiency virus (HIV)‐infected subjects selected from 3,14

Monitoring the response to antiretrovira
✍ Carmen de Mendoza; Wei Lu; Ana Machuca; María Sainz; Jesús Castilla; Vincent Sor 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

## Abstract Failure to recognise infection caused by human immunodeficiency virus type 1 (HIV‐1) group O variants has been described using both serological and genetic procedures. Moreover, monitoring the response to antiretroviral therapy is a difficult task in patients infected with HIV‐1 group O

Overcoming resistance to existing therap
✍ Carlo-Federico Perno; Graeme Moyle; Chris Tsoukas; Winai Ratanasuwan; Jose Gatel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as a major public health priority. As ARV resistance becomes more prevalent with extended use of existing agents, individuals with

Mutations associated with lamivudine-res
✍ S. Gloria Selabe; Azwidowi Lukhwareni; Ernest Song; Yeegan G.M. Leeuw; Rosemary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with

Expression levels of MDR1, MRP1, MRP4, a
✍ Ombretta Turriziani; Nicola Gianotti; Francesca Falasca; Arianna Boni; Anna Rita 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract The aim of the study was to evaluate the mRNA expression of four relevant ABC‐transporter genes [MDR1 (P‐glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV‐positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell co

No pol mutation is associated independen
✍ Nicola Gianotti; Laura Galli; Maurizio Zazzi; Valeria Ghisetti; Stefano Bonora; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

## Abstract An investigation was undertaken to determine whether specific __pol__ mutations hinder long‐term immune recovery regardless of virological response. In total, 826 patients with >50 HIV RNA copies/ml, who underwent genotypic resistance testing between 1 January 2000 and 31 December 2003